Fora Capital, LLC Takeda Pharmaceutical CO LTD Transaction History

Fora Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$13.12 - $15.03 $217,568 - $249,242	-16,583 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$13.54 - $15.35 $224,533 - $254,549	16,583 New	16,583 $239,000
Q2 2021 Aug 16, 2021	SELL	$16.55 - $18.64 $16,897 - $19,031	-1,021 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$16.71 - $19.9 $702,939 - $837,133	-42,067 Reduced 97.63%	1,021 $19 Million
Q4 2020 Feb 12, 2021	BUY	$15.39 - $18.97 $568,737 - $701,036	36,955 Added 602.56%	43,088 $784,000

Q3 2020 Nov 13, 2020	BUY	$17.1 - $19.19 $104,874 - $117,692	6,133 New	6,133 $109 Million
Q1 2020 May 15, 2020	SELL	$13.02 - $20.31 $325,213 - $507,303	-24,978 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.88 - $20.83 $421,628 - $520,291	24,978 New	24,978 $492,000

340

76M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.